Kolexia
Eveillard Marion Pharmacien
Eveillard Marion
Pharmacien
Hôpital Hôtel-Dieu Nantes
Nantes, France
152 Activités
122 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémie aigüe myéloïde Maladie résiduelle Myélome multiple Syndromes myélodysplasiques Lymphomes Leucémie myéloïde Thrombopénie

Collaborateurs

Voir plus
Bene Marie-Christine
Bene Marie-Christine
Hôpital Hôtel-Dieu Nantes, Nantes, France
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Peterlin Pierre
Peterlin Pierre
Hôpital Hôtel-Dieu Nantes, Nantes, France
Le Bris Yannick
Le Bris Yannick
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
Abbvie
4 collaboration(s)
Dernière en 2023
Amgen
4 collaboration(s)
Dernière en 2023
Sysmex
4 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
American journal of hematology   02 janvier 2024
Can academic structures improve access to CAR-T cells?.
Bulletin du cancer   28 novembre 2023
Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Deep Learning Based Blood Abnormalities Detection As a Tool for Vexas Syndrome Screening
65th ASH Annual Meeting Abstracts   02 novembre 2023
In Vitro Efficacy of Anti-HER2 CAR T-Cells in HER2 + BCP-ALL
65th ASH Annual Meeting Abstracts   02 novembre 2023
Optical Genome Mapping Combined with High-Throughput Sequencing Is Effective for the Diagnostic and Prognostic Genomic Classification of Acute Myeloid Leukemia and Myelodysplastic Neoplasms
65th ASH Annual Meeting Abstracts   02 novembre 2023
HILDEGAZ: Phase 1 Dose Escalation of Early Infusion of Zoledronic Acid in Combination With Increasing Low-dose of Interleukin-2 in Order to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allogeneic Stem Cell Transplantation (SCT)
Essai Clinique (CHU Nantes)   05 octobre 2023
Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial.
EClinicalMedicine   28 septembre 2023
Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients.
EJHaem   21 septembre 2023
Bone marrow necrosis in childhood: The hunt for blasts.
International journal of laboratory hematology   22 août 2023